Wedbush Reiterates Outperform on Tyra Biosciences, Maintains $27 Price Target
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Robert Driscoll has reiterated an Outperform rating on Tyra Biosciences (NASDAQ:TYRA) and maintained a price target of $27.

December 29, 2023 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush analyst reaffirms Outperform rating on Tyra Biosciences with a $27 price target, indicating a positive outlook on the stock.
The reiteration of an Outperform rating by a reputable analyst like Robert Driscoll from Wedbush is a strong positive signal for investors, suggesting that the analyst has a bullish outlook on the stock's future performance. The maintained price target of $27 implies a potential upside from the current trading price, which could influence investor sentiment and drive short-term price movement in a positive direction.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100